Raghu Keerthana, Surya R Janani, Rani Padmaja Kumari, Sharma Tarun, Raman Rajiv
Shri Bhagwan Mahavir Vitreoretinal Services, Sankara Nethralaya, Chennai, India.
Department of Biostatistics, National Institute of Epidemiology, Chennai, India.
Ophthalmic Epidemiol. 2025 Aug;32(4):428-436. doi: 10.1080/09286586.2024.2419015. Epub 2024 Nov 12.
To evaluate the 15 year incidence and progression of Diabetic Retinopathy (DR) and identify risk factors among Indian population. From a cross-sectional study of 1425 subjects, 911 participants took part in the 4-year follow-up. Out of these 911 participants, 140 returned for the 15-year follow-up, with baseline examinations conducted between 2003 and 2006, and subsequent follow-ups occurring from 2007 to 2011 and the current 15-year follow-up from 2018 to 2021. Of the 140 participants, 112 were eligible for analysis after excluding individuals with ungradable fundus photographs. The 15-year incidence of any diabetic retinopathy (DR) was 5%, with mild NPDR and moderate NPDR at 1.57% and 2.7%, respectively. Proliferative DR was observed in 0.71% of cases, while diabetic macular edema (DME) and sight-threatening diabetic retinopathy (STDR) rates were 0.48% and 1.10%, respectively. Age-standardized rates revealed a significant association with increasing age and incident any DR and STDR. DR progression over 15 years included 7.5% one-step and 1.75% two-step progressions, while regression was limited to 1.75% one-step regression. Multiple logistic regression analyses revealed that baseline duration of diabetes, systolic blood pressure, HbA1c levels, and the presence of anemia influenced the incidence of any DR, DME, and STDR. Smoking and higher HbA1c were identified as risk factors for one-step progression of DR. This study provides crucial insights into the long-term incidence, progression, and regression of DR among individuals with Type 2 diabetes in India.
评估印度人群中糖尿病视网膜病变(DR)的15年发病率及进展情况,并确定危险因素。在一项对1425名受试者的横断面研究中,911名参与者参加了为期4年的随访。在这911名参与者中,140人返回进行15年随访,基线检查于2003年至2006年进行,随后的随访分别在2007年至2011年以及当前的2018年至2021年15年随访期间进行。在这140名参与者中,排除眼底照片无法分级的个体后,112人符合分析条件。任何糖尿病视网膜病变(DR)的15年发病率为5%,轻度非增殖性糖尿病视网膜病变(NPDR)和中度NPDR的发病率分别为1.57%和2.7%。增殖性DR的发病率为0.71%,而糖尿病性黄斑水肿(DME)和威胁视力的糖尿病视网膜病变(STDR)的发病率分别为0.48%和1.10%。年龄标准化发病率显示,年龄增长与任何DR和STDR的发生之间存在显著关联。15年间DR的进展包括7.5%的一步进展和1.75%的两步进展,而逆转仅限于1.75%的一步逆转。多因素逻辑回归分析显示,糖尿病的基线病程、收缩压、糖化血红蛋白(HbA1c)水平以及贫血的存在会影响任何DR、DME和STDR的发病率。吸烟和较高的HbA1c被确定为DR一步进展的危险因素。本研究为印度2型糖尿病患者DR的长期发病率、进展和逆转情况提供了重要见解。